Colitis ulcerosa: vizsgálatok itt: Kína

In Kína 67 Also abroad 381

67 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
A Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Afimkibart (RO7790121) in Children With Moderately to Severely Active Ulcerative Colitis
Where
Hangzhou, Shanghai
Életkor
2 év to 17 év
People
100 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07158242 · EU 2025-522518-22-01
2. fázisTaking people
LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
Where
Changzhou, Chongqing, Fuzhou, Hangzhou, Kunming, Nanjing, Qingdao, Shenyang, Shijiazhuang, Taian, Wuhan, Wuxi
Életkor
18 év to 80 év
People
252 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07186101
2. fázisTaking people
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
Where
Binzhou, Changzhou, Chengdu, Chongqing, Foshan, Guangzhou, Harbin, Hefei, Huizhou, Kunming, Liaocheng, Meihekou, Qingdao, Shanghai, Shaoguan, Shenzhen, Suzhou, Taian, Wuhan, Zunyi
Életkor
18 év to 80 év
People
1431 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07415044
2. fázisTaking people
A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease
Where
Changsha, Changzhou, Guangzhou, Hangzhou, Huizhou, Suzhou, Wenzhou, Xiamen, Zhenjiang
Életkor
18 év to 80 év
People
60 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07483073 · EU 2025-524112-11-00
3. fázisTaking people
A Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
Where
Beijing, Changzhou, Hangzhou, Shanghai, Shenyang
Életkor
3 év to 64 év
People
196 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00
No phaseTaking people
A Real-World Study of Guselkumab in Chinese Participants With Ulcerative Colitis
Where
Beijing, Changzhou, Guangzhou, Hangzhou, Nanjing, Shenzhen, Shijiazhuang, Tianjin
Életkor
18 év and over
People
200
Run by
Xian-Janssen Pharmaceutical Ltd.
See details and how to joinNCT07302360
3. fázisTaking people
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Beijing, Changzhou, Chengdu, Chongqing, Foshan, Fuzhou, Guangzhou, Hangzhou, Hefei, Huai'an, Jinhua, Lanzhou, Luoyang, Ningbo, Shanghai, Shijiazhuang, Shiyan, Suzhou, Xiamen, Zhengzhou, Zhuzhou, Zunyi
Életkor
18 év and over
People
644 worldwide
Run by
Janssen Research & Development, LLC
See details and how to joinNCT07577856 · EU 2026-525923-26-00
2. fázisTaking people
Study Evaluating ISM5411 Administered Orally to Subjects With Active Ulcerative Colitis (BETHESDA)
Where
Beijing, Binzhou, Changsha, Chengdu, Chongqing, Ganzhou, Guangzhou, Hengyang, Huizhou, Kunming, Lishui, Luoyang, Nanjing, Nanning, Shanghai, Shenyang, Shijiazhuang, Taian, Taiyuan, Tianjin, Tonghua, Wenzhou, Wuhan, Xian, Xinxiang
Életkor
18 év to 75 év
People
80
Run by
InSilico Medicine Hong Kong Limited
See details and how to joinNCT07265570
2. fázisTaking people
A Study of AC-101 Tablets in Patients With Ulcerative Colitis
Where
Guangzhou
Életkor
18 év to 75 év
People
153
Run by
Accro Bioscience (Suzhou) Limited
See details and how to joinNCT07755241
2. fázisTaking people
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Where
Binzhou, Changchun, Chengdu, Fuzhou, Guangzhou, Hangzhou, Huizhou, Ningbo, Wuhan, Xiamen, Zhengzhou
Életkor
18 év and over
People
224 worldwide
Run by
Genentech, Inc.
See details and how to joinNCT06979336 · EU 2025-520690-39-00
3. fázisTaking people
A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
Where
Changchun, Changsha, Guangzhou, Hangzhou, Shanghai, Zhengzhou
Életkor
2 év to 17 év
People
120 worldwide
Run by
AbbVie
See details and how to joinNCT07071519 · EU 2024-514695-41-00
3. fázisTaking people
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Changshu, Chengdu, Jinhua, Luoyang, Luzhou, Shanghai, Wuhan
Életkor
16 év to 80 év
People
980 worldwide
Run by
Sanofi
See details and how to joinNCT07184996
Korai 1. fázisNot yet taking people in Kína
Oral Aeromonas sp. MTB Phage Therapy for Pouchitis in Patients With Ulcerative Colitis (UC)
Where
Nanjing
Életkor
18 év to 70 év
People
12
Run by
Jinling Hospital, China
See details and how to joinNCT07878026
No phaseTaking people
Efficacy and Safety of Guselkumab in Patients With Moderate-to-Severe Ulcerative Colitis
Where
Wenzhou
Életkor
18 év and over
People
97
Run by
Second Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT07726888
3. fázisTaking people
A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
Where
Beijing, Chengdu, Guangzhou, Hefei, Huizhou, Kunming, Shanghai, Wuxi
Életkor
16 év to 80 év
People
751 worldwide
Run by
Sanofi
See details and how to joinNCT07185009
1. fázisTaking people
A Study to Evaluate the Safety of SHR-7590 in Chinese Healthy Participants and in Patients With Moderate-to-severe Inflammatory Bowel Disease
Where
Hangzhou
Életkor
18 év to 55 év
People
88
Run by
Guangdong Hengrui Pharmaceutical Co., Ltd
See details and how to joinNCT07758101
2. fázisTaking people
Fecal Microbiota Transplantation for Ulcerative Colitis Using Dai and Han Donors
Where
Kunming
Életkor
18 év to 60 év
People
200
Run by
First Affiliated Hospital of Kunming Medical University
See details and how to joinNCT07814456
No phaseTaking people
Efficacy of Acupuncture-Mesalazine Combination Therapy in Ulcerative Colitis.
Where
Wuhan
Életkor
18 év to 75 év
People
66
Run by
Qin Yu
See details and how to joinNCT07389824
Korai 1. fázisTaking people
ND-12 Combined With H-6 for Adult Chronic Inflammatory Diarrhea
Where
Nanjing
Életkor
18 év to 75 év
People
36
Run by
The Second Hospital of Nanjing Medical University
See details and how to joinNCT07767370
1. fázisNot yet taking people in Kína
A Study to Evaluate the Safety, Tolerability, PK and Preliminary Efficacy of HX15001 Combined With Etrasimod in Moderate-severe Ulcerative Colitis
Where
Hefei
Életkor
18 év to 75 év
People
32
Run by
Helixon Biotechnology (Suzhou) Co., Ltd
See details and how to joinNCT07768254
2. fázisNot yet taking people in Kína
A Study to Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetics of PTT-621 in Patients With Moderately to Severely Active Ulcerative Colitis
Where
Shanghai
Életkor
18 év to 70 év
People
40
Run by
Pyrotech Therapeutics, Inc.
See details and how to joinNCT07747155
1. fázisNot yet taking people in Kína
Alpha-0261 Tablets for Moderate-to-Severe Ulcerative Colitis
Where
Hefei
Életkor
18 év to 75 év
People
10
Run by
The First Affiliated Hospital of Anhui Medical University
See details and how to joinNCT07744646
No phaseTaking people
Real-World Effectiveness and Safety of Upadacitinib Plus Vedolizumab vs Upadacitinib Monotherapy During Induction in Moderate-to-Severe Ulcerative Colitis
Where
Foshan, Guangzhou, Shenzhen
Életkor
18 év and over
People
150
Run by
Sixth Affiliated Hospital, Sun Yat-sen University
See details and how to joinNCT07442045
No phaseTaking people
DYNAMIC-UC: Early qFIT and Calprotectin Change Predicting Relapse in Biologic-Naive Ulcerative Colitis
Where
Jinan
Életkor
18 év to 75 év
People
100
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT07111273
No phaseTaking people
Fecal biOmarker Response Evaluation for Super-Early Efficacy in Ulcerative Colitis
Where
Jinan
Életkor
18 év to 75 év
People
100
Run by
Qilu Hospital of Shandong University
See details and how to joinNCT07111572